Debt-to-equity of ENDRA Life Sciences Inc. from 30 Sep 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ENDRA Life Sciences Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2017 to 30 Sep 2025.
  • ENDRA Life Sciences Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 108%, a 375% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ENDRA Life Sciences Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 108% +85% +375% 30 Sep 2025
Q2 2025 52% +25% +93% 30 Jun 2025
Q1 2025 33% -1% -1.8% 31 Mar 2025
Q4 2024 30% -6% -17% 31 Dec 2024
Q3 2024 23% -15% -39% 30 Sep 2024
Q2 2024 27% -3% -11% 30 Jun 2024
Q1 2024 33% +10% +41% 31 Mar 2024
Q4 2023 36% +16% +77% 31 Dec 2023
Q3 2023 38% +19% +102% 30 Sep 2023
Q2 2023 30% +13% +72% 30 Jun 2023
Q1 2023 24% +6% +36% 31 Mar 2023
Q4 2022 20% +7% +52% 31 Dec 2022
Q3 2022 19% +5% +40% 30 Sep 2022
Q2 2022 17% +1% +9.3% 30 Jun 2022
Q1 2022 17% -5% -22% 31 Mar 2022
Q4 2021 13% -39% -75% 31 Dec 2021
Q3 2021 13% -57% -81% 30 Sep 2021
Q2 2021 16% -71% -82% 30 Jun 2021
Q1 2021 22% -53% -70% 31 Mar 2021
Q4 2020 53% -5% -9% 31 Dec 2020
Q3 2020 71% +30% +74% 30 Sep 2020
Q2 2020 87% +44% +101% 30 Jun 2020
Q1 2020 75% +34% +85% 31 Mar 2020
Q4 2019 58% +14% +30% 31 Dec 2019
Q3 2019 41% -7% -15% 30 Sep 2019
Q2 2019 43% +25% +138% 30 Jun 2019
Q1 2019 40% +31% +327% 31 Mar 2019
Q4 2018 44% +27% +158% 31 Dec 2018
Q3 2018 48% +18% +59% 30 Sep 2018
Q2 2018 18% 30 Jun 2018
Q1 2018 9% 31 Mar 2018
Q4 2017 17% 31 Dec 2017
Q3 2017 30% 30 Sep 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.